Wahidin Sudirohusodo Hospital
Makassar, South Sulawesi, 90245, Indonesia
NCT Number: NCT06706271
The goal of this clinical trial is to analyze the effects of in vitamin D3 on serum hepcidin and ferritin levels among children with chronic kidney disease. The main questions it aims to answer is:
"What is the effect of giving vitamin D3 on serum hepcidin and ferritin levels in children with chronic kidney disease?"
We will compare the effect of vitamin D3 administration on hepcidin and ferritin between 2 groups. Group A consists of children with GFR more 90 mL/min/1,73 m2. Group B consists of children with GFR less than 90 mL/min/1,73 m2
Participants will be given the same 2000 IU of Vitamin D/day for 6 weeks.
Looking for future studies?
Notify Me2 year–18 year
All sexes
Interventional
Phase 2 / Phase 3
Makassar, South Sulawesi, 90245, Indonesia
The primary objective of the study is to analyze the effects of vitamin D3 administration on serum levels of hepcidin and ferritin in children diagnosed with CKD. The research aims to measure these serum levels before and after vitamin D3 supplementation across different stages of kidney function, categorized by glomerular filtration rate (GFR). Specifically, it seeks to determine whether vitamin D3 can effectively reduce hepcidin levels and improve iron status as indicated by ferritin levels. The study employs a structured methodology involving children with CKD, divided into two groups based on their GFR: those with GFR < 90 mL/min/1.73 m² and those with GFR ≥ 90 mL/min/1.73 m². Serum levels of vitamin D, hepcidin, and ferritin will be measured at baseline (before supplementation) and after a defined period of vitamin D3 administration. The research will utilize statistical analyses to compare these values within and between groups to establish any significant changes attributable to the supplementation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2000 IU of Vitamin D
Time frame: From enrollment to the end of treatment at 6 weeks
Vitamin D is measured before and after supplementation of Vitamin D
Time frame: From enrollment to the end of treatment at 6 weeks
Ferritin level before and after Vitamin D supplementation
Time frame: From enrollment to the end of treatment at 6 weeks
Hepcidin level before and after Vitamin D supplementation
Hasanuddin University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04617431
Chronic Disease, Chronic Kidney Disease Stage 1
Douliu, Taiwan
View Trial DetailsNCT07309094
Body Weight, Chronic Disease
Valencia, Spain
View Trial DetailsNCT04960514
Chronic Disease, Chronic Kidney Disease Stage 1
Winston-Salem, North Carolina, United States
View Trial DetailsNCT05198284
Chronic Disease, Chronic Kidney Disease Stage 1
New York, United States
View Trial Details